Earth Science Tech, Inc. (OTC: ETST), a strategic holding company focused on a diversified portfolio, has announced the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products based in Doral, Florida. This move is set to integrate Zoolzy into ETST's supply chain, enabling its compounding pharmacies to procure APIs at competitive wholesale pricing, which the company says could increase overall profit margins.
The acquisition is a pivotal step for ETST as it broadens access to novel APIs for custom compounding and provides immediate procurement access to common veterinary medications. By leveraging Zoolzy's distribution capabilities, ETST plans to expand into the animal health market with unique, flavored, and easy-to-administer veterinary therapeutics. This initiative will be led by members of its management team who have experience and established networks in the exotic wildlife space, positioning the company to capitalize on a growing demand for specialized veterinary products.
Zoolzy operates from a 3,684-square-foot facility and is expected to become an integral part of ETST's vertically integrated healthcare platform. The company's strategy is to build a seamless integration of patient care, from consultation to fulfillment, through the synergy of its specialized subsidiaries. This acquisition aligns with that strategy by strengthening the supply chain and opening new distribution channels.
According to the company, the acquisition will not only improve cost efficiencies but also enhance the range of products available to its compounding pharmacies. This could lead to increased profitability and a stronger competitive position in the health and wellness sector. The move into veterinary medicine represents a diversification that could mitigate risks associated with the human pharmaceutical market and tap into a growing industry.
ETST's focus on vertical integration is evident in its portfolio, which includes compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The addition of Zoolzy is expected to support these operations by ensuring a reliable and cost-effective supply of APIs. Furthermore, the company's investments in real estate and asset management activities, as well as its consumer products business, provide a stable foundation for growth.
This acquisition comes at a time when the pharmaceutical supply chain is under scrutiny for vulnerabilities, and companies are seeking to secure their sources of essential ingredients. By owning a distributor, ETST gains greater control over its supply chain, reducing dependence on third-party suppliers and potentially insulating itself from price fluctuations. This strategic move could serve as a model for other small-cap pharmaceutical companies looking to enhance their operational resilience.
For more information about Earth Science Tech and its recent developments, visit the company's newsroom at https://ibn.fm/ETST. To view the full press release, see https://ibn.fm/nHFqQ.
